204 related articles for article (PubMed ID: 24651583)
1. Genetic polymorphisms in metabolizing enzymes modifying the association between smoking and inflammatory bowel diseases.
Ananthakrishnan AN; Nguyen DD; Sauk J; Yajnik V; Xavier RJ
Inflamm Bowel Dis; 2014 May; 20(5):783-9. PubMed ID: 24651583
[TBL] [Abstract][Full Text] [Related]
2. Genetic variants of glutathione S-transferases mu, theta, and pi display no susceptibility to inflammatory bowel disease in the Danish population.
Ernst A; Andersen V; Østergaard M; Jacobsen BA; Dagiliene E; Pedersen IS; Drewes AM; Okkels H; Krarup HB
Scand J Gastroenterol; 2010 Sep; 45(9):1068-75. PubMed ID: 20459366
[TBL] [Abstract][Full Text] [Related]
3. GSTA1, GSTM1, GSTP1, and GSTT1 polymorphisms and susceptibility to smoking-related bladder cancer: a case-control study.
Matic M; Pekmezovic T; Djukic T; Mimic-Oka J; Dragicevic D; Krivic B; Suvakov S; Savic-Radojevic A; Pljesa-Ercegovac M; Tulic C; Coric V; Simic T
Urol Oncol; 2013 Oct; 31(7):1184-92. PubMed ID: 24075358
[TBL] [Abstract][Full Text] [Related]
4. Genetic Polymorphisms of Xenobiotic Metabolizing Genes (GSTM1, GSTT1, GSTP1), Gene-Gene Interaction with Association to Lung Cancer Risk in North India; A Case Control Study.
Ritambhara ; Tiwari S; Vijayaraghavalu S; Kumar M
Asian Pac J Cancer Prev; 2019 Sep; 20(9):2707-2714. PubMed ID: 31554367
[TBL] [Abstract][Full Text] [Related]
5. The polymorphism rs3024505 proximal to IL-10 is associated with risk of ulcerative colitis and Crohns disease in a Danish case-control study.
Andersen V; Ernst A; Christensen J; Østergaard M; Jacobsen BA; Tjønneland A; Krarup HB; Vogel U
BMC Med Genet; 2010 May; 11():82. PubMed ID: 20509889
[TBL] [Abstract][Full Text] [Related]
6. Cigarette smoking, genetic polymorphisms and colorectal cancer risk: the Fukuoka Colorectal Cancer Study.
Nisa H; Kono S; Yin G; Toyomura K; Nagano J; Mibu R; Tanaka M; Kakeji Y; Maehara Y; Okamura T; Ikejiri K; Futami K; Maekawa T; Yasunami Y; Takenaka K; Ichimiya H; Terasaka R
BMC Cancer; 2010 Jun; 10():274. PubMed ID: 20534171
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms of drug-metabolizing genes and risk of non-Hodgkin lymphoma.
Kim HN; Kim NY; Yu L; Kim YK; Lee IK; Yang DH; Lee JJ; Shin MH; Park KS; Choi JS; Kim HJ
Am J Hematol; 2009 Dec; 84(12):821-5. PubMed ID: 19899130
[TBL] [Abstract][Full Text] [Related]
8. Dietary Iron and Heme Iron Consumption, Genetic Susceptibility, and Risk of Crohn's Disease and Ulcerative Colitis.
Khalili H; de Silva PS; Ananthakrishnan AN; Lochhead P; Joshi A; Garber JJ; Richter JR; Sauk J; Chan AT
Inflamm Bowel Dis; 2017 Jul; 23(7):1088-1095. PubMed ID: 28604414
[TBL] [Abstract][Full Text] [Related]
9. A retrospective, case-control study on traditional environmental risk factors in inflammatory bowel disease in Vukovar-Srijem County, north-eastern Croatia, 2010.
Vcev A; Pezerovic D; Jovanovic Z; Nakic D; Vcev I; Majnarić L
Wien Klin Wochenschr; 2015 May; 127(9-10):345-54. PubMed ID: 25821054
[TBL] [Abstract][Full Text] [Related]
10. Differential Impact of Smoking on Methylome and Transcriptome in Crohn's Disease and Ulcerative Colitis.
Yan Ang Q; Plichta D; Kim S; Hyun-A Kim I; Gregory S; Xia Y; Lau H; Xavier R; Ananthakrishnan AN
Inflamm Bowel Dis; 2024 Jun; 30(6):981-991. PubMed ID: 38001042
[TBL] [Abstract][Full Text] [Related]
11. Is current smoking still an important environmental factor in inflammatory bowel diseases? Results from a population-based incident cohort.
Lakatos PL; Vegh Z; Lovasz BD; David G; Pandur T; Erdelyi Z; Szita I; Mester G; Balogh M; Szipocs I; Molnar C; Komaromi E; Golovics PA; Mandel M; Horvath A; Szathmari M; Kiss LS; Lakatos L
Inflamm Bowel Dis; 2013 Apr; 19(5):1010-7. PubMed ID: 23399739
[TBL] [Abstract][Full Text] [Related]
12. Association between self-reported environmental tobacco smoke exposure and lung cancer: modification by GSTP1 polymorphism.
Miller DP; De Vivo I; Neuberg D; Wain JC; Lynch TJ; Su L; Christiani DC
Int J Cancer; 2003 May; 104(6):758-63. PubMed ID: 12640684
[TBL] [Abstract][Full Text] [Related]
13. Eosinophil associated genes in the inflammatory bowel disease 4 region: correlation to inflammatory bowel disease revealed.
Blom K; Rubin J; Halfvarson J; Törkvist L; Rönnblom A; Sangfelt P; Lördal M; Jönsson UB; Sjöqvist U; Håkansson LD; Venge P; Carlson M
World J Gastroenterol; 2012 Nov; 18(44):6409-19; discussion p. 6417-8. PubMed ID: 23197886
[TBL] [Abstract][Full Text] [Related]
14. Influence of glutathione S-transferases (GSTM1, GSTT1, and GSTP1) genetic polymorphisms and smoking on susceptibility risk of chronic myeloid leukemia and treatment response.
Rostami G; Assad D; Ghadyani F; Hamid M; Karami A; Jalaeikhoo H; Kalahroodi RA
Mol Genet Genomic Med; 2019 Jul; 7(7):e00717. PubMed ID: 31111691
[TBL] [Abstract][Full Text] [Related]
15. Genetic Factors Interact With Tobacco Smoke to Modify Risk for Inflammatory Bowel Disease in Humans and Mice.
Yadav P; Ellinghaus D; Rémy G; Freitag-Wolf S; Cesaro A; Degenhardt F; Boucher G; Delacre M; ; Peyrin-Biroulet L; Pichavant M; Rioux JD; Gosset P; Franke A; Schumm LP; Krawczak M; Chamaillard M; Dempfle A; Andersen V
Gastroenterology; 2017 Aug; 153(2):550-565. PubMed ID: 28506689
[TBL] [Abstract][Full Text] [Related]
16. Associations between vitamin D receptor polymorphisms and susceptibility to ulcerative colitis and Crohn's disease: a meta-analysis.
Xue LN; Xu KQ; Zhang W; Wang Q; Wu J; Wang XY
Inflamm Bowel Dis; 2013 Jan; 19(1):54-60. PubMed ID: 22467262
[TBL] [Abstract][Full Text] [Related]
17. Distinct and overlapping genetic loci in Crohn's disease and ulcerative colitis: correlations with pathogenesis.
Waterman M; Xu W; Stempak JM; Milgrom R; Bernstein CN; Griffiths AM; Greenberg GR; Steinhart AH; Silverberg MS
Inflamm Bowel Dis; 2011 Sep; 17(9):1936-42. PubMed ID: 21830272
[TBL] [Abstract][Full Text] [Related]
18. Smoking and inflammatory bowel disease: trends in familial and sporadic cohorts.
Tuvlin JA; Raza SS; Bracamonte S; Julian C; Hanauer SB; Nicolae DL; King AC; Cho JH
Inflamm Bowel Dis; 2007 May; 13(5):573-9. PubMed ID: 17345609
[TBL] [Abstract][Full Text] [Related]
19. Significance of the genetic polymorphism of CYP2D6 and NAT2 in patients with inflammatory bowel diseases.
Dudarewicz M; Rychlik-Sych M; Barańska M; Wojtczak A; Trzciński R; Dziki A; Skrętkowicz J
Pharmacol Rep; 2014 Aug; 66(4):686-90. PubMed ID: 24948072
[TBL] [Abstract][Full Text] [Related]
20. Genetic Polymorphisms in Fatty Acid Metabolism Modify the Association Between Dietary n3: n6 Intake and Risk of Ulcerative Colitis: A Prospective Cohort Study.
Ananthakrishnan AN; Khalili H; Song M; Higuchi LM; Lochhead P; Richter JM; Chan AT
Inflamm Bowel Dis; 2017 Nov; 23(11):1898-1904. PubMed ID: 28991856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
